510 related articles for article (PubMed ID: 36558344)
1. Nanoparticles in Drug Delivery: From History to Therapeutic Applications.
Afzal O; Altamimi ASA; Nadeem MS; Alzarea SI; Almalki WH; Tariq A; Mubeen B; Murtaza BN; Iftikhar S; Riaz N; Kazmi I
Nanomaterials (Basel); 2022 Dec; 12(24):. PubMed ID: 36558344
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Concepts on Smart Nano-Based Drug Delivery System.
Rai S; Singh N; Bhattacharya S
Recent Pat Nanotechnol; 2022; 16(1):67-89. PubMed ID: 33494685
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
[TBL] [Abstract][Full Text] [Related]
5. Nano-based drug delivery system for therapeutics: a comprehensive review.
Prakash S
Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
[TBL] [Abstract][Full Text] [Related]
6. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
7. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
8. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
9. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer.
Banthia P; Gambhir L; Sharma A; Daga D; Kapoor N; Chaudhary R; Sharma G
3 Biotech; 2022 Mar; 12(3):70. PubMed ID: 35223356
[TBL] [Abstract][Full Text] [Related]
10. Advances and challenges in nanocarriers and nanomedicines for veterinary application.
Carvalho SG; Araujo VHS; Dos Santos AM; Duarte JL; Silvestre ALP; Fonseca-Santos B; Villanova JCO; Gremião MPD; Chorilli M
Int J Pharm; 2020 Apr; 580():119214. PubMed ID: 32165220
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based materials in anticancer drug delivery: Current and future prospects.
Ajith S; Almomani F; Elhissi A; Husseini GA
Heliyon; 2023 Nov; 9(11):e21227. PubMed ID: 37954330
[TBL] [Abstract][Full Text] [Related]
12. Nano drug-delivery systems for management of AIDS: liposomes, dendrimers, gold and silver nanoparticles.
Asl FD; Mousazadeh M; Taji S; Bahmani A; Khashayar P; Azimzadeh M; Mostafavi E
Nanomedicine (Lond); 2023 Feb; 18(3):279-302. PubMed ID: 37125616
[TBL] [Abstract][Full Text] [Related]
13. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
14. Conventional Nanosized Drug Delivery Systems for Cancer Applications.
Vergallo C; Hafeez MN; Iannotta D; Santos HA; D'Avanzo N; Dini L; Cilurzo F; Fresta M; Di Marzio L; Christian C
Adv Exp Med Biol; 2021; 1295():3-27. PubMed ID: 33543453
[TBL] [Abstract][Full Text] [Related]
15. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.
Peng C; Huang Y; Zheng J
J Control Release; 2020 Jun; 322():64-80. PubMed ID: 32194171
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
17. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
Hock SC; Ying YM; Wah CL
PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
[TBL] [Abstract][Full Text] [Related]
18. Advantages and limitations of nanostructures for biomedical applications.
Roszkowski S; Durczynska Z
Adv Clin Exp Med; 2024 Jun; ():. PubMed ID: 38860712
[TBL] [Abstract][Full Text] [Related]
19. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
20. What nanomedicine in the clinic right now really forms nanoparticles?
Svenson S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
